[Crizotinib treatment for a lung adenocarcinoma patient with anaplastic lymphoma kinase gene rearrangement and disseminated intravascular coagulation].
Cited by 0
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
|Cancer Research|2022|108
Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation
|Lung Cancer|2019|102
Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma
|Biochemical and Biophysical Research Communications|2015|55